Benitec Biopharma News

Benitec Biopharma | 4: Statement of changes in beneficial ownership of securities-Director SUVRETTA CAPITAL MANAGEMENT, LLC

Nov 21 16:30 ET

Benitec Biopharma | SC 13D/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Suvretta Capital Management, LLC(49.9%),Aaron Cowen(49.9%), etc.

Nov 18 16:41 ET

Benitec Biopharma | SCHEDULE 13G: Others

Nov 14 16:58 ET

Benitec Biopharma | 8-K: Benitec Biopharma Releases First Quarter 2025 Financial Results and Provides Operational Update

Nov 14 16:44 ET

Benitec Biopharma | DEFA14A: Others

Nov 14 16:44 ET

Benitec Biopharma | 10-Q: Q1 2025 Earnings Report

Nov 14 16:39 ET

Benitec Biopharma | 8-K: Current report

Nov 14 16:37 ET

Benitec Biopharma | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Janus Henderson Group plc(8.3%),Janus Henderson Biotech Innovation Master Fund Ltd(6.4%)

Nov 14 13:43 ET

Benitec Biopharma | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-HBM Healthcare Investments (Cayman) Ltd.(9.7%)

Nov 13 16:24 ET

Benitec Biopharma | EFFECT: Others

Nov 13 06:09 ET

Benitec Biopharma | SCHEDULE 13G/A: Others

Nov 7 12:33 ET

Benitec Biopharma | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Janus Henderson Group plc(13.5%),Janus Henderson Biotech Innovation Master Fund Ltd(10.3%)

Nov 6 15:32 ET

Benitec Biopharma | S-3: Registration statement for specified transactions by certain issuers

Nov 1 17:08 ET

Benitec Biopharma | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Janus Henderson Group plc(13.5%)

Oct 25 14:22 ET

Benitec Biopharma | DEFA14A: Others

Oct 22 17:28 ET

Benitec Biopharma | DEF 14A: Definitive information statements

Oct 22 09:25 ET

Benitec Biopharma | 8-K: Current report

Oct 15 08:09 ET

Benitec Biopharma | 424B5: Prospectus

Oct 15 06:18 ET

Benitec Biopharma | 424B5: Prospectus

Oct 11 17:14 ET

Benitec Biopharma | PRE 14A: Preliminary proxy statements relating to merger or acquisition

Oct 11 16:54 ET